2026 Longevity Medicine Conference: Experts Endorse, Industry Leaders Praise-HSAP's Comprehensive Cognitive Health Solution Draws Significant Industry Attention
From April 24 to 26, the 2026 Academic Exchange Conference on Longevity Medicine and Related Technology Exhibition was grandly held in Shenzhen, Guangdong, jointly organized by authoritative institutions including the China Health Promotion Foundation, the China Association of Geriatric Health Care, the China Anti-Aging Promotion Association, the China Health Management Association, and the Guangdong Association of Geriatric Health Care. HSAP was invited to attend the event, showcasing its full-chain equipment for cognitive health-covering prevention, screening, diagnosis, treatment, and rehabilitation-along with innovative management models. The company joined leading global experts in exploring new pathways for the development of longevity medicine and brain health, attracting significant attention from the industry.
This conference focuses on cutting-edge technologies in longevity medicine and the development of the senior health industry. It brings together leading experts, industry leaders, and corporate representatives from fields such as geriatrics, neuroscience, and health management both domestically and internationally. Participants will engage in in-depth discussions on core topics including the prevention and treatment of cognitive impairment, innovations in senior wellness and care, and the commercialization of longevity technologies, thereby injecting new momentum into the high-quality development of China's longevity medicine sector. As a leading company in the field of cognitive health management, HSAP showcased its full range of proprietary cognitive health devices at the exhibition area, becoming a highlight of the conference.
Keynote Presentation by a Leading Expert
End-to-End Cognitive Management: The Key to Longevity
During the academic exchange session, Professor Huang Yue-Attending Physician in the Department of Neurology at Beijing Tiantan Hospital (affiliated with Capital Medical University) and Researcher at the Brain Bank of the National Clinical Research Center for Neurological Diseases-delivered a keynote presentation. Focusing on the prevention and treatment of cognitive impairment and the establishment of a comprehensive management system, she shared cutting-edge academic insights and practical solutions with the audience.
In his report, Professor Huang Yue clearly stated that the prevention and treatment of cognitive impairment must prioritize early detection and early intervention, and that establishing a closed-loop management system covering the entire process-from screening to intervention-is the key to achieving healthy longevity. Currently, traditional cognitive impairment diagnosis and treatment suffer from "fragmented and disjointed" challenges, with prominent issues such as difficulties in early screening, weak intervention, and disorganized management, which severely limit the effectiveness of maintaining cognitive health in the elderly. A closed-loop management system, however, uses technological synergy to integrate the entire process-from prevention, screening, and diagnosis to treatment and rehabilitation-providing a systematic, replicable, and scalable model for elderly cognitive health that helps address these industry challenges.
Regarding the prevention and treatment of Alzheimer's disease (AD), Professor Huang Yue emphasized that early intervention is key, and large-scale population-based early screening is a prerequisite for achieving early intervention. The ADDS cognitive impairment screening system demonstrated at HSAP precisely addresses this need. Integrating brain-computer interface and artificial intelligence technologies, the system uses a human-machine interaction model to complete a multidimensional quantitative assessment of memory, attention, and executive function in just 15 minutes. It meets the precise diagnostic needs of top-tier hospitals while also being suitable for large-scale population screening in community settings, providing efficient and accurate technical support for early AD screening.
In the field of early intervention for Alzheimer's disease, Professor Huang Yue highlighted the HSAP ADTS Memory Impairment Training System. Based on the principles of neuroplasticity and utilizing non-invasive brain-computer interface technology, the system allows patients to wear lightweight EEG devices and use their thoughts to "focus" or "relax" to drive the progress of rehabilitation games. This effectively activates the prefrontal cortex, enhancing multidimensional cognitive abilities such as attention, memory, and calculation skills, and provides a safe, non-invasive, non-pharmacological intervention pathway for neurodegenerative diseases.
Leading Experts Visit and Praise the System
Innovative Treatment Equipment Draws Significant Attention
During the conference, delegations of leaders and experts from the China Health Promotion Foundation, the China Association of Geriatric Health Care, the China Anti-Aging Promotion Association, the China Health Management Association, and the Guangdong Provincial Association of Geriatric Health Care visited the HSAP booth. They conducted a detailed inspection of the full-chain equipment for cognitive health screening, training, diagnosis, and treatment, and highly commended the company's technological innovations and closed-loop management model.
The device that attracted the most attention at the event was HSAP's latest Alzheimer's disease treatment device (the ADMS Cognitive Neurostimulation System). This device overcomes the limitations of traditional intervention techniques by integrating multisensory stimulation technologies-including visual, auditory, and tactile inputs-with photobiomodulation of specific brain regions and ultra-low-frequency whole-body magnetic field stimulation. It induces broader and more intense gamma oscillations in the brain, precisely targeting deep brain regions associated with Alzheimer's disease-such as the hippocampus, insula, and amygdala-to effectively alleviate neurodegenerative changes and dementia symptoms in patients. Currently, the device has officially entered the clinical trial phase and is expected to provide a novel treatment option for AD patients, propelling China's non-pharmacological AD treatment technologies to new heights.
Experts at the conference noted that HSAP's comprehensive cognitive health management system and closed-loop management model precisely align with national strategies for the prevention and control of dementia in the elderly. By effectively addressing the challenges in the diagnosis and treatment of cognitive disorders, the system offers a "Chinese solution" for cognitive health management among the elderly, holding significant clinical value and social significance.
Over a Decade of Dedication
Empowering "Healthy China" Through Comprehensive Innovation
As a pioneer in China's cognitive health management sector, HSAP has dedicated over a decade to the biomedical field. Always grounded in the essential health needs of the Chinese population, the company leverages core technologies such as bioimpedance, biomimetic pulse magnetic resonance, brain-computer interfaces, and neurostimulation to independently develop a full range of professional medical devices. Through innovation, HSAP has established a Chinese model for closed-loop management of cognitive disorders that comprehensively covers the entire chain of "prevention, screening, diagnosis, treatment, and rehabilitation."
From early-stage health risk assessments for prevention, to the ADDS system for precise screening and specialized equipment for standardized diagnosis, to the ADMS system for targeted treatment and ADTS training equipment for comprehensive wellness and care, HSAP has developed an integrated cognitive health solution. Its products are widely used in various settings, including top-tier hospitals, community health service centers, and senior care facilities, helping to build a comprehensive neuro-health service network.
HSAP's participation in the 2026 Longevity Medicine Conference serves not only as a showcase of its core technologies and innovative achievements in the prevention and treatment of cognitive disorders but also as a demonstration of the company's commitment to the Healthy China initiative and its active involvement in the fields of longevity medicine and geriatric health. Moving forward, HSAP will remain dedicated to technological innovation, deepen its expertise in cognitive health, and continuously optimize its end-to-end equipment and management models. The company is committed to building a robust defense for the cognitive health of hundreds of millions of elderly people and contributing to the high-quality development of China's elderly care and wellness sector.
